Eczema: all 1,088 studies

Page 3 of 11. Open to participants first (130), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.CompletedNCT04250337Phase 3Results posted
• Tofacitinib for Immune Skin Conditions in Down SyndromeCompletedNCT04246372Phase 2Results posted
• Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic DermatitisCompletedNCT04212169Phase 2Results posted
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic DermatitisCompletedNCT04178967Phase 3Results posted
• A Phase II Study in Adult Patients With Moderate to Severe Atopic DermatitisCompletedNCT04162899Phase 2Results posted
• A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT04162769Phase 2Results posted
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)CompletedNCT04146363Phase 3Results posted
• Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)TerminatedNCT04140695Phase 3Results posted
• A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic DermatitisCompletedNCT04040192Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic DermatitisCompletedNCT04021862Phase 2Results posted
• Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT03989349Phase 3Results posted
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT03985943Phase 3Results posted
• Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic DermatitisCompletedNCT03981926Not applicableResults posted
• Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic DermatitisCompletedNCT03961529Phase 3Results posted
• Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic DermatitisCompletedNCT03954158Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic DermatitisCompletedNCT03952559Phase 3Results posted
• A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis PatientsTerminatedNCT03948334Phase 2Results posted
• A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)CompletedNCT03921411Phase 2Results posted
• Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic DermatitisCompletedNCT03916081Phase 2Results posted
• Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic DermatitisCompletedNCT03915496Phase 2Results posted
• Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic DermatitisCompletedNCT03912259Phase 3Results posted
• Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic DermatitisCompletedNCT03911401Phase 3Results posted
• Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndromeCompletedNCT03908970Phase 3Results posted
• Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic DermatitisCompletedNCT03903822Phase 2Results posted
• A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin BarrierCompletedNCT03901144Phase 2Results posted
• A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic DermatitisTerminatedNCT03864627Phase 2Results posted
• Clobetasol Topical Oil for Children With Moderate to Severe Atopic DermatitisTerminatedNCT03847389Phase 1/2Results posted
• A Study of LY3375880 in Adults With Moderate-to-Severe Atopic DermatitisTerminatedNCT03831191Phase 2Results posted
• Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic DermatitisCompletedNCT03824405Phase 2Results posted
• Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)CompletedNCT03823794Results posted
• Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic DermatitisTerminatedNCT03817190Phase 2Results posted
• A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic DermatitisTerminatedNCT03809663Phase 2Results posted
• JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic DermatitisCompletedNCT03796676Phase 3Results posted
• A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic DermatitisCompletedNCT03775434Phase 1Results posted
• Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7CompletedNCT03761537Phase 3Results posted
• An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic DermatitisCompletedNCT03758716Phase 2Results posted
• A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic DermatitisCompletedNCT03747575Phase 2Results posted
• TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic DermatitisCompletedNCT03745651Phase 3Results posted
• Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic DermatitisCompletedNCT03745638Phase 3Results posted
• Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisTerminatedNCT03738423Phase 2Results posted
• A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT03738397Phase 3Results posted
• A Clinical Investigation With Epaderm® CreamCompletedNCT03738163Not applicableResults posted
• Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic DermatitisTerminatedNCT03736967Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic DermatitisCompletedNCT03733301Phase 3Results posted
• Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand EczemaCompletedNCT03728504Phase 2Results posted
• Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.CompletedNCT03725722Phase 2Results posted
• Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical TherapyCompletedNCT03720470Phase 3Results posted
• A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic DermatitisCompletedNCT03706040Phase 2Results posted
• Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic DermatitisCompletedNCT03703102Phase 2Results posted
• Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand EczemaCompletedNCT03683719Phase 2Results posted
• The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis PatientsCompletedNCT03667014Phase 4Results posted
• Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic DermatitisTerminatedNCT03654755Phase 2Results posted
• ASPIRE: PROs & Caregiver Burden in Children With Atopic DermatitisCompletedNCT03645057Phase 3Results posted
• Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring SubjectsCompletedNCT03627767Phase 3Results posted
• Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTENDCompletedNCT03587805Phase 3Results posted
• A Study of ATI-502 Topical Solution for the Treatment of Atopic DermatitisCompletedNCT03585296Phase 2Results posted
• Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic DermatitisCompletedNCT03575871Phase 3Results posted
• Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)CompletedNCT03568331Phase 3Results posted
• Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic DermatitisCompletedNCT03568162Phase 2Results posted
• Effect of Benralizumab in Atopic DermatitisCompletedNCT03563066Phase 2Results posted
• Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)CompletedNCT03562377Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic DermatitisTerminatedNCT03559270Phase 3Results posted
• A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate ADTerminatedNCT03539601Phase 4Results posted
• Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT03533751Phase 2Results posted
• Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)CompletedNCT03531957Phase 2Results posted
• Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).CompletedNCT03526861Phase 3Results posted
• A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic DermatitisTerminatedNCT03517566Phase 2Results posted
• A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03496974Phase 2Results posted
• A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic DermatitisCompletedNCT03492398Phase 1Results posted
• A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT03443024Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT03435081Phase 3Results posted
• A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically AdvisableCompletedNCT03428100Phase 3Results posted
• A Community-based Assessment of Skin Care, Allergies, and EczemaCompletedNCT03409367Not applicableResults posted
• Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic DermatitisTerminatedNCT03389893Phase 4Results posted
• 8-Week Atopic Dermatitis (AD) Treatment StudyCompletedNCT03386032Phase 3Results posted
• Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3CompletedNCT03363854Phase 3Results posted
• A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic DermatitisCompletedNCT03356977Phase 4Results posted
• Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic DermatitisCompletedNCT03349060Phase 3Results posted
• A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic DermatitisCompletedNCT03334435Phase 3Results posted
• Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03334422Phase 3Results posted
• A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03334396Phase 3Results posted
• Immunogenetic Profiling of Dupilumab for the Treatment of Atopic DermatitisCompletedNCT03293030Phase 4Results posted
• A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic DermatitisCompletedNCT03260595Phase 1Results posted
• Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic DermatitisCompletedNCT03250624Phase 2Results posted
• Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic DermatitisCompletedNCT03235024Phase 2Results posted
• Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic DermatitisCompletedNCT03233529Phase 2Results posted
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)CompletedNCT03160885Phase 3Results posted
• Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis PatientsCompletedNCT03158012Phase 1Results posted
• Targeted Microbiome Transplant in Atopic DermatitisCompletedNCT03151148Phase 1/2Results posted
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)CompletedNCT03131648Phase 3Results posted
• Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic DermatitisCompletedNCT03107611Phase 3Results posted
• Dose-ranging Study of Nemolizumab in Atopic DermatitisCompletedNCT03100344Phase 2Results posted
• Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult SubjectsCompletedNCT03058783Phase 3Results posted
• Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic DermatitisTerminatedNCT03055195Phase 2Results posted
• Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic DermatitisCompletedNCT03054428Phase 3Results posted
• Evaluating Treatment Resistant Dermatitis TaroIIRCompletedNCT03050294Phase 4Results posted
• Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic DermatitisCompletedNCT03018691Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic DermatitisCompletedNCT03011892Phase 2Results posted
• Insulin Sensitivity in Patients With Atopic DermatitisCompletedNCT03003793Results posted
• Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)CompletedNCT03002571Phase 3Results posted

← Eczema overview